Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The C9orf72 GGGGCC repeat expansion is a major cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD).Non-conventional repeat translation results in five dipeptide repeat proteins (DPRs), but their clinical utility, overall significance, and temporal course in the pathogenesis of c9ALS/FTD are unclear, although animal models support a gain-of-function mechanism.Here, we established a poly-GP immunoassay from cerebrospinal fluid (CSF) to identify and characterize C9orf72 patients.Significant poly-GP levels were already detectable in asymptomatic C9orf72 mutation carriers compared to healthy controls and patients with other neurodegenerative diseases.The poly-GP levels in asymptomatic carriers were similar to symptomatic c9ALS/FTD cases.Poly-GP levels were not correlated with disease onset, clinical scores, and CSF levels of neurofilaments as a marker for axonal damage.Poly-GP determination in CSF revealed a C9orf72 mutation carrier in our cohort and may thus be used as a diagnostic marker in addition to genetic testing to screen patients.Presymptomatic expression of poly-GP and likely other DPR species may contribute to disease onset and thus represents an alluring therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In C9orf72 expansion carriers, poly(GP), one of the DPR proteins produced by the C9orf72 expansions, is elevated as early as the presymptomatic phase.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Formation of repeat RNA foci in the nucleus and the accompanying sequestration of RNA-binding proteins are thought to alter RNA processing (DeJesus-Hernandez et al, 2011).”
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases with similar neuropathological features and overlapping clinical symptoms and pathomechanisms (Ling et al, 2013).”
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Self-citationAsh, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 903
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Bañez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 760
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740 · cited 2×
“Since poly-GR/PR and poly-GA are by far more toxic than polyGP in cellular and animal models (Mizielinska et al, 2014), it will be critical to determine their levels during disease progression to better address the role of DPRs in c9ALS/FTD pathogenesis.”
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Gendron, T. F., Bieniek, K. F., Zhang, Y.-J., Jansen-West, K., Ash, P. E. A., Caulfield, T., Daughrity, L., Dunmore, J. H., Castanedes-Casey, M., Chew, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1192-8 · Cited by 581
Cited by
Items 101–137 of 137
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Prudlo, J., & Hermann, A. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00007-6 · Cited by 1
Étude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00033-7
Research Advances in Diagnostic Methods for Prevalent Neurological Diseases
Lv, M., Sun, X., & Wang, X. (2026) · Biosensors · doi:10.3390/bios16070368
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00003-0
Chen, M., Li, H., & Jin, Q. (2026) · Diagnostics · doi:10.3390/diagnostics16172857
Autosomal Dominant Frontotemporal Lobar Degeneration: From Genotype to Phenotype
Serpente, M., & Galimberti, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_8
Soriani, M.-H., Blasco, H., Corcia, P., Danel-Brunaud, V., Desmaison, A., Pradat, P., Querin, G., Vourc’h, P., & Guy, N. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.07.008
Major Neurocognitive Disorders Due to Frontotemporal Disease
Gopalakrishna, G., Sarangi, A., & Joshi, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_4
de Mello, A. A. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-19042024-164334
Liu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19181413
Liu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19181410
Neuroimaging biomarkers in genetic frontotemporal dementia : towards a timely diagnosis
Feis, R. A. (2020) · Leiden Repository (Leiden University)
Arogundade, O. A., Jiang, J., & Ravits, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00009-4
Prudlo, J., & Hermann, A. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21882-8.00007-4
Improving Wellbeing in At-Risk Frontotemporal Dementia
Greaves, C. V. (2024) · UCL Discovery (University College London)
Novel digital biomarkers for frontotemporal dementia
Convery, R. S. (2023) · UCL Discovery (University College London)
Analysis of the C9orf72 dipeptide-repeat proteins and characterization of a poly-GA mouse model
Schludi, M. H. (2018) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.22655
Self-citationInvestigating Adenosine Deaminase and Purine Metabolism in C9orf72 Amyotrophic Lateral Sclerosis
Hall, B. (2023) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Zainaba, N., Mahdawi, F. A. A., & Alwakaa, O. (2026) · Innovative Medicines & Omics · doi:10.36922/imo025430056
Sharma, N., & An, S. S. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125537
Sonobe, Y., Lee, S., Krishnan, G., Gu, Y., Kwon, D. Y., Gao, F., Roos, R. P., & Kratsios, P. (2023) · eLife · doi:10.7554/elife.83189.sa2
Smeele, P. H., Ferrari, V., Spina, G., Doná, E., Cauchi, R., Poletti, A., & Vaccari, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.09.765393
Marjanović, A. (2023) · National Repository of Dissertations in Serbia
Ashman, C. J. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Protein and MRI profiling of genetic frontotemporal dementia
Ullgren, A. (2024) · Open Archive (Karolinska Institutet)
Biomarkers and psychological stress in amyotrophic lateral sclerosis
Kläppe, U. (2023) · Open Archive (Karolinska Institutet)
REGULATION OF C9ORF72 FTD/ALS PATHOLOGY BY UBIQUILIN-2
Welday, J. P. (2019) · Deep Blue (University of Michigan) · doi:10.7302/2471
Metadata
- Authors
- Lehmer, C., Oeckl, P., Weishaupt, J. H., Volk, A. E., Diehl‐Schmid, J., Schroeter, M. L., Lauer, M., Kornhuber, J., Levin, J., Fassbender, K., Landwehrmeyer, B., German Consortium for Frontotemporal Lobar Degeneration, Schludi, M. H., Arzberger, T., Kremmer, E., Flatley, A., Feederle, R., Steinacker, P., Weydt, P., Ludolph, A. C., Edbauer, D., Otto, M., Danek, A., Feneberg, E., Anderl‐Straub, S., von Arnim, C., Jahn, H., Schneider, A., Maler, M., Polyakova, M., Riedl, L., Wiltfang, J., & Ziegler, G.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Ulm (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Technical University of Munich (DE)
- University Hospital Leipzig (DE)
- Universitätsklinikum Würzburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Saarland University (DE)
- Helmholtz Munich (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Edbauer, Dieter
- Otto, Markus
- ORCID
- Oeckl, Patrick
- Weishaupt, Jochen H
- Volk, Alexander E
- Diehl‐Schmid, Janine
- Schroeter, Matthias L
- Lauer, Martin
- Kornhuber, Johannes
- Levin, Johannes
- Fassbender, Klaus
- Kremmer, Elisabeth
- Flatley, Andrew
- Feederle, Regina
- Steinacker, Petra
- Weydt, Patrick
- Ludolph, Albert C
- Edbauer, Dieter
- Otto, Markus
- Danek, Adrian
- Feneberg, Emily
- Jahn, Holger
- Schneider, Anja
- Wiltfang, Jens
- Ziegler, Georg
- Venue
- EMBO Molecular Medicine
- Published
- 2017-04-13
- Volume
- 9
- Issue
- 7
- Pages
- 859-868
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC5494528
- OpenAlex
- W2606980242
- Cited by
- 118
- References
- 41
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 9 · 2020: 11 · 2019: 15 · 2018: 19 · 2017: 4
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, cc-by)
- DZNE Pub (submittedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- JPND Networks SOPHIA (01ED1202A)
- BiomarkAPD (01ED1203F)
- PreFrontAls (01ED1512)
- STRENGTH (01ED1408)
- EU (246513, 633190, 617198)
- German Research Foundation/DFG (VO2028)
- Baden‐Württemberg (D.3830)
- BIU (D.5009)
- Charcot Foundation
- NOMIS Foundation
- Seventh Framework Programme (617198)
- Bundesministerium für Bildung und Forschung (O1GI1007A, 01GM1103A)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- C9orf72, GGGGCC repeat expansion, dipeptide repeat proteins, cerebrospinal fluid biomarkers, amyotrophic lateral sclerosis, frontotemporal dementia, presymptomatic carriers, gain-of-function mechanism, disease onset, neurofilaments, immunoassay
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid, Cross-Sectional Studies, Dipeptides, Humans, Immunoassay, Peptides, Biomarkers, Gene Expression, Repetitive Sequences, Amino Acid, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.